rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6 Pt 1
|
pubmed:dateCreated |
2004-11-11
|
pubmed:abstractText |
Erectile dysfunction (ED) is a common sequel of pelvic fracture urethral disruption (PFUD). After repair of the urethral injury ED may be the most devastating long-term effect for the patient. Some patients with ED may regain normal erectile function. We prospectively studied the response to sildenafil and the erectile function of patients with ED due to PFUD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-5347
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
172
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2350-2
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15538265-Adolescent,
pubmed-meshheading:15538265-Adult,
pubmed-meshheading:15538265-Algorithms,
pubmed-meshheading:15538265-Erectile Dysfunction,
pubmed-meshheading:15538265-Fractures, Bone,
pubmed-meshheading:15538265-Humans,
pubmed-meshheading:15538265-Male,
pubmed-meshheading:15538265-Middle Aged,
pubmed-meshheading:15538265-Pelvic Bones,
pubmed-meshheading:15538265-Phosphodiesterase Inhibitors,
pubmed-meshheading:15538265-Piperazines,
pubmed-meshheading:15538265-Prospective Studies,
pubmed-meshheading:15538265-Purines,
pubmed-meshheading:15538265-Sulfones,
pubmed-meshheading:15538265-Urethra
|
pubmed:year |
2004
|
pubmed:articleTitle |
The role of sildenafil in the treatment of erectile dysfunction in patients with pelvic fracture urethral disruption.
|
pubmed:affiliation |
Department of Urology, Hebrew University Hadassah Medical Center, Jerusalem, Israel.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|